| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 9 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 5, no: 4 |
| NetGPI | no | yes: 0, no: 9 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 5 |
| GO:0110165 | cellular anatomical entity | 1 | 5 |
Related structures:
AlphaFold database: A4HI36
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 12 | 14 | PF00675 | 0.397 |
| CLV_NRD_NRD_1 | 171 | 173 | PF00675 | 0.749 |
| CLV_NRD_NRD_1 | 217 | 219 | PF00675 | 0.475 |
| CLV_PCSK_KEX2_1 | 12 | 14 | PF00082 | 0.397 |
| CLV_PCSK_KEX2_1 | 171 | 173 | PF00082 | 0.596 |
| CLV_PCSK_KEX2_1 | 217 | 219 | PF00082 | 0.482 |
| DEG_MDM2_SWIB_1 | 25 | 33 | PF02201 | 0.213 |
| DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.353 |
| DOC_MAPK_gen_1 | 199 | 208 | PF00069 | 0.568 |
| DOC_PP1_RVXF_1 | 107 | 114 | PF00149 | 0.466 |
| DOC_PP2B_LxvP_1 | 206 | 209 | PF13499 | 0.670 |
| DOC_PP2B_LxvP_1 | 211 | 214 | PF13499 | 0.678 |
| DOC_PP4_FxxP_1 | 18 | 21 | PF00568 | 0.213 |
| DOC_USP7_MATH_1 | 107 | 111 | PF00917 | 0.438 |
| DOC_USP7_MATH_1 | 138 | 142 | PF00917 | 0.447 |
| DOC_USP7_MATH_1 | 177 | 181 | PF00917 | 0.380 |
| DOC_USP7_MATH_1 | 60 | 64 | PF00917 | 0.627 |
| DOC_WW_Pin1_4 | 151 | 156 | PF00397 | 0.496 |
| DOC_WW_Pin1_4 | 170 | 175 | PF00397 | 0.581 |
| LIG_14-3-3_CanoR_1 | 109 | 114 | PF00244 | 0.459 |
| LIG_14-3-3_CanoR_1 | 119 | 124 | PF00244 | 0.344 |
| LIG_14-3-3_CanoR_1 | 172 | 182 | PF00244 | 0.384 |
| LIG_14-3-3_CanoR_1 | 37 | 41 | PF00244 | 0.591 |
| LIG_14-3-3_CanoR_1 | 43 | 52 | PF00244 | 0.299 |
| LIG_14-3-3_CterR_2 | 217 | 222 | PF00244 | 0.596 |
| LIG_Actin_WH2_2 | 129 | 146 | PF00022 | 0.505 |
| LIG_BRCT_BRCA1_1 | 109 | 113 | PF00533 | 0.399 |
| LIG_Clathr_ClatBox_1 | 133 | 137 | PF01394 | 0.467 |
| LIG_FHA_1 | 106 | 112 | PF00498 | 0.412 |
| LIG_FHA_1 | 124 | 130 | PF00498 | 0.389 |
| LIG_FHA_1 | 151 | 157 | PF00498 | 0.452 |
| LIG_FHA_1 | 203 | 209 | PF00498 | 0.565 |
| LIG_FHA_1 | 45 | 51 | PF00498 | 0.457 |
| LIG_FHA_1 | 94 | 100 | PF00498 | 0.417 |
| LIG_IRF3_LxIS_1 | 155 | 161 | PF10401 | 0.502 |
| LIG_LIR_Gen_1 | 110 | 121 | PF02991 | 0.466 |
| LIG_LIR_Nem_3 | 110 | 116 | PF02991 | 0.358 |
| LIG_LIR_Nem_3 | 28 | 33 | PF02991 | 0.595 |
| LIG_PCNA_yPIPBox_3 | 80 | 92 | PF02747 | 0.457 |
| LIG_Pex14_2 | 25 | 29 | PF04695 | 0.213 |
| LIG_SH2_CRK | 30 | 34 | PF00017 | 0.422 |
| LIG_SH2_NCK_1 | 57 | 61 | PF00017 | 0.233 |
| LIG_SH2_PTP2 | 86 | 89 | PF00017 | 0.385 |
| LIG_SH2_STAP1 | 34 | 38 | PF00017 | 0.545 |
| LIG_SH2_STAP1 | 57 | 61 | PF00017 | 0.233 |
| LIG_SH2_STAT5 | 86 | 89 | PF00017 | 0.385 |
| LIG_SH3_3 | 124 | 130 | PF00018 | 0.439 |
| LIG_SUMO_SIM_par_1 | 124 | 131 | PF11976 | 0.479 |
| LIG_SUMO_SIM_par_1 | 204 | 210 | PF11976 | 0.595 |
| LIG_WRC_WIRS_1 | 160 | 165 | PF05994 | 0.345 |
| MOD_CK1_1 | 145 | 151 | PF00069 | 0.480 |
| MOD_CK1_1 | 161 | 167 | PF00069 | 0.334 |
| MOD_CK1_1 | 170 | 176 | PF00069 | 0.571 |
| MOD_CK1_1 | 181 | 187 | PF00069 | 0.432 |
| MOD_CK1_1 | 48 | 54 | PF00069 | 0.437 |
| MOD_CK2_1 | 161 | 167 | PF00069 | 0.535 |
| MOD_GlcNHglycan | 101 | 104 | PF01048 | 0.627 |
| MOD_GlcNHglycan | 144 | 147 | PF01048 | 0.662 |
| MOD_GlcNHglycan | 175 | 178 | PF01048 | 0.694 |
| MOD_GlcNHglycan | 183 | 186 | PF01048 | 0.400 |
| MOD_GlcNHglycan | 4 | 7 | PF01048 | 0.718 |
| MOD_GSK3_1 | 105 | 112 | PF00069 | 0.373 |
| MOD_GSK3_1 | 115 | 122 | PF00069 | 0.356 |
| MOD_GSK3_1 | 138 | 145 | PF00069 | 0.433 |
| MOD_GSK3_1 | 146 | 153 | PF00069 | 0.459 |
| MOD_GSK3_1 | 173 | 180 | PF00069 | 0.509 |
| MOD_GSK3_1 | 25 | 32 | PF00069 | 0.434 |
| MOD_GSK3_1 | 44 | 51 | PF00069 | 0.433 |
| MOD_NEK2_1 | 105 | 110 | PF00069 | 0.371 |
| MOD_NEK2_1 | 136 | 141 | PF00069 | 0.472 |
| MOD_NEK2_1 | 158 | 163 | PF00069 | 0.401 |
| MOD_NEK2_1 | 25 | 30 | PF00069 | 0.351 |
| MOD_NEK2_1 | 36 | 41 | PF00069 | 0.586 |
| MOD_NEK2_1 | 59 | 64 | PF00069 | 0.597 |
| MOD_NEK2_2 | 29 | 34 | PF00069 | 0.424 |
| MOD_PKA_2 | 36 | 42 | PF00069 | 0.549 |
| MOD_Plk_1 | 123 | 129 | PF00069 | 0.451 |
| MOD_Plk_4 | 138 | 144 | PF00069 | 0.451 |
| MOD_Plk_4 | 25 | 31 | PF00069 | 0.401 |
| MOD_Plk_4 | 45 | 51 | PF00069 | 0.455 |
| MOD_ProDKin_1 | 151 | 157 | PF00069 | 0.496 |
| MOD_ProDKin_1 | 170 | 176 | PF00069 | 0.581 |
| TRG_DiLeu_BaLyEn_6 | 18 | 23 | PF01217 | 0.213 |
| TRG_ENDOCYTIC_2 | 30 | 33 | PF00928 | 0.421 |
| TRG_ENDOCYTIC_2 | 86 | 89 | PF00928 | 0.364 |
| TRG_ER_diArg_1 | 11 | 13 | PF00400 | 0.349 |
| TRG_ER_diArg_1 | 216 | 218 | PF00400 | 0.627 |
| TRG_ER_diArg_1 | 40 | 43 | PF00400 | 0.570 |
| TRG_NES_CRM1_1 | 69 | 82 | PF08389 | 0.418 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1IM14 | Leptomonas seymouri | 46% | 100% |
| A0A1X0P359 | Trypanosomatidae | 34% | 100% |
| A0A3S7X383 | Leishmania donovani | 79% | 100% |
| A0A422P4T9 | Trypanosoma rangeli | 35% | 100% |
| A4I5B2 | Leishmania infantum | 79% | 100% |
| C9ZQP6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 30% | 100% |
| E9B0K8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 78% | 100% |
| Q4Q7M4 | Leishmania major | 79% | 100% |